Indeed, Ehrlich and colleagues reported that CDK5 activity blockade in hepatocellular carcinoma cell lines prevented ATM phosphorylation and then blocked the initiation of the DNA damage response, including the G2/M arrest [25]. Here, CDK5 is linked to hepatocellular carcinoma.